Sequential therapy with caspofungin and Fluconazole for Candida albicans infection

被引：6
作者：
Barchiesi, F
Spreghini, E
Baldassarri, I
Marigliano, A
Arzeni, D
Giannini, D
Scalise, G
机构：
[1] Univ Politecn Marche, Ist Malaitte Infett & Med Pubbl, I-60020 Ancona, Italy
[2] Univ Politecn Marche, Ctr Gestione Presidenza Med & Chirurg, I-60020 Ancona, Italy
来源：
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 2004年 / 48卷 / 10期
关键词：
D O I：
10.1128/AAC.48.10.4056-4058.2004
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
A sequential therapy of caspofungin (CAS) and fluconazole (FLC) administration for treatment of Candida albicans infection was investigated. Treatment with CAS followed by FLC was as effective as CAS treatment given alone for the same duration. Our data suggest that switching from CAS to FLC is a potentially explorable therapeutic option for treatment of systemic candidiasis.
引用
收藏
页码：4056 / 4058
页数：3
相关论文
共 14 条
[1]   In vitro synergy of caspofungin and amphotericin B against Aspergillus and Fusarium spp. [J].
Arikan, S ;
Lozano-Chiu, M ;
Paetznick, V ;
Rex, JH .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (01) :245-247
[2]   In vitro activity of caspofungin (MK-0991) against Candida albicans clinical isolates displaying different mechanisms of azole resistance [J].
Bachmann, SP ;
Patterson, TF ;
López-Ribot, JL .
JOURNAL OF CLINICAL MICROBIOLOGY, 2002, 40 (06) :2228-2230
[3]  
Barchiesi F, 1999, EUR J CLIN MICROBIOL, V18, P302
[4]   In vitro preclinical evaluation studies with the echinocandin antifungal MK-0991 (L-743,872) [J].
Bartizal, K ;
Gill, CJ ;
Abruzzo, GK ;
Flattery, AM ;
Kong, L ;
Scott, PM ;
Smith, JG ;
Leighton, CE ;
Bouffard, A ;
Dropinski, JF ;
Balkovec, J .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (11) :2326-2332
[5]  
COMO JA, 1994, NEW ENGL J MED, V330, P263, DOI 10.1056/NEJM199401273300407
[6]   Addition of caspofungin to fluconazole does not improve outcome in murine candidiasis [J].
Graybill, JR ;
Bocanegra, R ;
Najvar, LK ;
Hernandez, S ;
Larsen, RA .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2003, 47 (07) :2373-2375
[7]   Efficacy of caspofungin alone and in combination with voriconazole in a guinea pig model of invasive aspergillosis [J].
Kirkpatrick, WR ;
Perea, S ;
Coco, BJ ;
Patterson, TF .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (08) :2564-2568
[8]   Combination chemotherapy for invasive fungal infections: what laboratory and clinical studies tell us so far [J].
Kontoyiannis, DP ;
Lewis, RE .
DRUG RESISTANCE UPDATES, 2003, 6 (05) :257-269
[9]   Comparison of caspofungin and amphotericin B for invasive candidiasis. [J].
Mora-Duarte, J ;
Betts, R ;
Rotstein, C ;
Colombo, AL ;
Thompson-Moya, L ;
Smietana, J ;
Lupinacci, R ;
Sable, C ;
Kartsonis, N ;
Perfect, J .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (25) :2020-2029
[10]  
National Committee for Clinical Laboratory Standards, 2002, 727A2 NAT COMM CLIN
12